• Logo
  • SBMUJournals

Characterization of the “a” determinant Region of the Hepatitis B Virus genome in Iranian Patients at Different clinical phases of Chronic Infection

Sara Romani, Seyed Masoud Hosseini, Seyed Reza Mohebbi, Andre Boonstra, Armin Hosseini Razavi, Afsaneh Sharifian




Aim: To determine the distribution of important mutations of the “a” determinant region in the HBV genome among patients in different
clinical phases of HBV infection.
Background: Variations in Hepatitis B infection not only change the outcome of the disease but also the symptoms from which the
chronic HBV patients are suffering.
Methods: We have meticulously selected a total of 40 chronic HBV patients from four different subclasses of chronic HBV clinical
phases including immune tolerant (IT), immune active (IA), inactive carrier (IC) and hepatitis B e antigen (HBeAg)-negative (ENEG);
10 samples per each phase. Mutations of the “a” determinant region were identified using PCR-Direct sequencing method.
Results: 17 amino-acid substitutions at 12 positions inside the “a” determinant were identified in all forty samples; 3 mutations in the
IT group, 6 mutations in the IA phase, 3 mutations in the IC patients and 5 mutations in the ENEG phase. Different substitutions were
observed in all four clinical phases. The IA phase was the most variant group with the highest number of amino-acid substitutions.
Conclusion: These results did not reveal a strong pattern to distinguish different clinical phases of Chronic HBV infection, but there
are some obvious differences regarding the number and position of mutations between these four clinical phases.
Keywords: “a” determinant region, Chronic hepatitis B infection, Clinical phases, Amino-acid substitution.
(Please cite as: Romani S, Hosseini SM, Mohebbi SR, Boonstra A, Hosseini Razavi A, Sharifian A. Characterization
of the “a” determinant region of the hepatitis B virus genome in Iranian patients at different clinical phases of
chronic infection. Gastroenterol Hepatol Bed Bench 2018;11(2):131-137).


“a” determinant region, Chronic Hepatitis B infection, Clinical phases, Amino Acid substitution


Chen H-B, Fang D-X, Li F-Q, Jing H-Y, Tan W-G, Li S-Q. A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene. World Journal of Gastroenterology : WJG. 2003; 9[2]:304-8.

Shizuma T, Hasegawa K, Ishikawa K, et al. Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus. J Gastroenterol. 2003; 38[3]:244-53.

Khan N, Guarnieri M, Ahn SH, et al. Modulation of Hepatitis B Virus Secretion by Naturally Occurring Mutations in the S Gene. J Virol. 2004; 78[7]:3262-70.

Chiou HL, Lee TS, Kuo J, Mau YC, Ho MS. Altered antigenicity of 'a' determinant variants of hepatitis B virus. The Journal of general virology. 1997; 78 [ Pt 10]:2639-45.

Gao S, Duan ZP, Coffin CS. Clinical relevance of hepatitis B virus variants. World journal of hepatology. 2015; 7[8]:1086-96.

Harrison TJ, Oon CJ, Zuckerman AJ. A Novel Antibody Escape Variant [Ala 144] of Hepatitis B Virus in an Identical Twin Before Selection in the Mother. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease: Proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow, Tokyo, May 10–14, 1993 [1993 ISVHLD]. Tokyo: Springer Japan, 1994: 248-51.

Oon CJ, Tan KL, Harrison T, Zuckerman A. Natural history of hepatitis B surface antigen mutants in children. Lancet. 1996; 348[9040]:1524.

Oon CJ, Chen WN, Goh KT, et al. Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc. J Gastroenterol Hepatol. 2002; 17:S491-S6.

Brind A, Jiang J, Samuel D, et al. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol. 1997; 26[2]:228-35.

Carman WF, Van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology. 1997; 26[6]:1658-66.

Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo CG. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis. 1997; 176[5]:1360-5.

Protzer-Knolle U, Naumann U, Bartenschlager R, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology. 1998; 27[1]:254-63.

Roznovsky L, Harrison TJ, Fang ZL, et al. Unusual hepatitis B surface antigen variation in a child immunised against hepatitis B. J Med Virol. 2000; 61[1]:11-4.

Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol. 2002; 68[1]:50-9.

Oon CJ, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine. 1995; 13[8]:699-702.

Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997; 4 Suppl 1:11-20.

Chong-Jin O, Wei Ning C, Shiuan K, Gek Keow L. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J Infect Dis. 1999; 179[1]:259-63.

He C, Nomura F, Itoga S, Isobe K, Nakai T. Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J Gastroenterol Hepatol. 2001; 16[12]:1373-7.

Lee KM, Kim YS, Ko YY, et al. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci. 2001; 16[3]:359-62.

Seddigh-Tonekaboni S, Lim WL, Young B, et al. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient. J Viral Hepat. 2001; 8[2]:154-8.

Torresi J, Earnest-Silveira L, Civitico G, et al. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology. 2002; 299[1]:88-99.

Yamamoto K, Horikita M, Tsuda F, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol. 1994; 68[4]:2671-6.

Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet. 1995; 345[8962]:1406-7.

Francois G, Kew M, Van Damme P, Mphahlele MJ, Meheus A. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine. 2001; 19[28-29]:3799-815.

Zuckerman AJ, Zuckerman JN. Molecular epidemiology of hepatitis B virus mutants. J Med Virol. 1999; 58[3]:193-5.

Zheng X, Weinberger KM, Gehrke R, et al. Mutant hepatitis B virus surface antigens [HBsAg] are immunogenic but may have a changed specificity. Virology. 2004; 329[2]:454-64.

Chen WN, Oon CJ. Changes in the Antigenicity of a Hepatitis B Virus Mutant Stemming from Lamivudine Therapy. Antimicrobial Agents and Chemotherapy. 2000; 44[6]:1765.

Avellon A, Echevarria JM. Frequency of hepatitis B virus 'a' determinant variants in unselected Spanish chronic carriers. J Med Virol. 2006; 78[1]:24-36.

Song BC, Kim SH, Kim H, et al. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol. 2005; 76[2]:194-202.

Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008; 14[9]:858-66.

Romani S, Hosseini SM, Mohebbi SR, Boonstra A, Sharifian A. Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection. J Viral Hepat. 2017:n/a-n/a.

Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis. 1999; 180[5]:1444-51.

Sugauchi F, Orito E, Ichida T, et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology. 2003; 124[4]:925-32.

Shi Y, Wei F, Hu D, et al. Mutations in the major hydrophilic region [MHR] of hepatitis B virus genotype C in North China. Journal of medical virology. 2012; 84[12]:1901-6.

Chakravarty R, Neogi M, Roychowdhury S, Panda CK. Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus research. 2002; 90[1-2]:133-41.

Alexopoulou A, Baltayiannis G, Jammeh S, Waters J, Dourakis SP, Karayiannis P. Hepatitis B Surface Antigen Variant with Multiple Mutations in the a Determinant in an Agammaglobulinemic Patient. Journal of Clinical Microbiology. 2004; 42[6]:2861-5.

Salpini R, Colagrossi L, Bellocchi MC, et al. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology [Baltimore, Md]. 2015; 61[3]:823-33.

Shahmoradi S, Somi MH, Norouzi M, et al. HBsAg Mutants Clustered Mainly Outside of “a” Determinant in Chronic Carriers From Azarbayjan Province, Iran. Jundishapur J Microbiol. 2013; 6[6]:e6570.

Tran TT. Immune Tolerant Hepatitis B: A Clinical Dilemma. Gastroenterology & Hepatology. 2011; 7[8]:511-6.

Ghabeshi S, Sharifi Z, Hosseini SM, Mahmoodian Shooshtari M. Correlation Between Viral Load of HBV in Chronic Hepatitis B Patients and Precore and Basal Core Promoter Mutations. Hepatitis Monthly. 2013; 13[2]:e7415.

DOI: https://doi.org/10.22037/ghfbb.v0i0.1226